Alnylam Pharmace. buy Biotechhunter
Start price
20.05.20
/
50%
€130.48
Target price
26.06.20
-
Performance (%)
6.53%
End price
26.06.20
€139.00
Summary
This prediction ended on 26.06.20 with a price of €139.00. The BUY prediction by Biotechhunter finished with a performance of 6.53%. Biotechhunter has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | 4.034% | 4.034% | -48.106% | 18.712% |
| iShares Core DAX® | 0.881% | 5.632% | 8.477% | 63.917% |
| iShares Nasdaq 100 | 2.390% | 1.571% | 28.412% | 91.986% |
| iShares Nikkei 225® | 4.269% | 2.521% | 50.984% | 83.957% |
| iShares S&P 500 | 1.171% | 2.545% | 23.603% | 71.357% |
Comments by Biotechhunter for this prediction
In the thread Alnylam Pharmace. diskutieren
Buy Alnylam Pharmace.